Industry Insights & News 2018-10-28T20:05:45+00:00

Industry News

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

FDA OKs First Ingestible mHealth Sensor for Medication Adherence

mHealthIntelligence (Eric Wicklund) -- Federal regulators have approved the first digestible digital therapeutic, a pill with embedded sensors and an mHealth patch designed to help with medication adherence. The U.S. Food and Drug Administration announced approval late [...]

Is There a Doctor In My Pocket?

The Economist 1843 (Natasha Loder) -- Humans have always dreamed of better, fitter, longer-lasting bodies. But while many science-fiction fantasies, from videophones to self-driving cars, have been realised, health technology has lagged behind our hopes. Artificial [...]

Load More Posts

DTx Research & Studies

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Load More Posts

Stay Up To Date

SIGN UP FOR DTA NEWS & UPDATES

Sign Up Now